Suppr超能文献

抗心律失常药物和低钾血症对心脏复极速率适应性的影响。

Effects of antiarrhythmics and hypokalemia on the rate adaptation of cardiac repolarization.

作者信息

Osadchii Oleg E

机构信息

a Department of Biomedical Sciences , University of Copenhagen , Copenhagen , Denmark.

b Department of Health Science and Technology , University of Aalborg , Aalborg , Denmark.

出版信息

Scand Cardiovasc J. 2018 Aug;52(4):218-226. doi: 10.1080/14017431.2018.1478123. Epub 2018 May 25.

Abstract

OBJECTIVES

In normal conditions, sudden heart rate acceleration provokes a rapid reduction in ventricular action potential duration (APD). The protracted APD rate adaptation favors early afterdepolarizations and precipitates arrhythmia. Nevertheless, it is uncertain as to whether the rate-dependent changes of ventricular repolarization can be adversely modified by arrhythmogenic drugs (quinidine and procainamide) and hypokalemia, in comparison to the agents with safe therapeutic profile, such as lidocaine.

DESIGN

The rate adaptation of QT interval and monophasic APD obtained from the left ventricular (LV) and the right ventricular (RV) epicardium was examined during rapid cardiac pacing applied in isolated, perfused guinea-pig heart preparations.

RESULTS

At baseline, an abrupt increase in cardiac activation rate was associated with a substantial reduction of the QT interval and ventricular APD in the first two cardiac cycles, which was followed by a gradual shortening of repolarization over subsequent pacing intervals. The time constants of the fast (τ) and slow (τ) components of the APD dynamics determined from a double exponential fit were longer in RV compared to LV chamber. Quinidine, procainamide, and hypokalemia prolonged ventricular repolarization and delayed the rate adaptation of the QT interval and APD in LV and RV, as evidenced by increased τ and τ values. In contrast, lidocaine had no effect on the dynamic changes of ventricular repolarization upon heart rate acceleration.

CONCLUSIONS

The rate adaptation of ventricular repolarization is delayed by arrhythmogenic interventions, such as quinidine, procainamide, and hypokalemia, but not changed by lidocaine, a clinically safe antiarrhythmic agent.

摘要

目的

在正常情况下,心率突然加快会导致心室动作电位时程(APD)迅速缩短。APD速率适应性延长有利于早期后除极并促发心律失常。然而,与利多卡因等具有安全治疗特性的药物相比,致心律失常药物(奎尼丁和普鲁卡因胺)和低钾血症是否会对心室复极的速率依赖性变化产生不利影响尚不确定。

设计

在离体灌注豚鼠心脏标本中进行快速心脏起搏时,检测左心室(LV)和右心室(RV)心外膜的QT间期和单相APD的速率适应性。

结果

在基线时,心脏激活速率突然增加与前两个心动周期中QT间期和心室APD的显著缩短相关,随后在随后的起搏间期复极逐渐缩短。通过双指数拟合确定的APD动力学快速(τ)和慢速(τ)成分的时间常数在RV中比LV腔更长。奎尼丁、普鲁卡因胺和低钾血症延长了心室复极,并延迟了LV和RV中QT间期和APD的速率适应性,τ和τ值增加证明了这一点。相比之下,利多卡因对心率加快时心室复极的动态变化没有影响。

结论

致心律失常干预措施,如奎尼丁、普鲁卡因胺和低钾血症,会延迟心室复极的速率适应性,但临床安全的抗心律失常药物利多卡因不会改变这种适应性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验